VIVENDY THERAPEUTICS

Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly

#People #Financial #Website #More

VIVENDY THERAPEUTICS

Industry:

Biotechnology Health Diagnostics Therapeutics

Founded:

2006-01-01

Address:

Basel, Basel-Stadt, Switzerland

Country:

Switzerland

Website Url:

http://www.vivendy.ch

Total Employee:

11+

Status:

Closed

Contact:

41 61 271 87 80

Email Addresses:

[email protected]

Total Funding:

45.93 M USD

Technology used in webpage:

Domain Not Resolving

Current Employees Featured

dinko-valerio_image

Dinko Valerio
Dinko Valerio Supervisory Boards @ Vivendy Therapeutics
Supervisory Boards

not_available_image

Gertrud Thormann Huber
Gertrud Thormann Huber Director Clinical and Regulatory Affairs @ Vivendy Therapeutics
Director Clinical and Regulatory Affairs

not_available_image

Florian Fischer
Florian Fischer CFO @ Vivendy Therapeutics
CFO

not_available_image

Dr.Gosse Bruinsma
Dr.Gosse Bruinsma Executive Director @ Vivendy Therapeutics
Executive Director